(Q34102828)

31 July 2017

1 reference

title

Breast cancer chemoprevention. (English)

1 reference

31 July 2017

Rosenbaum Smith SM

1

1 reference

31 July 2017

Osborne MP

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

The American Journal of Surgery

31 July 2017

published in

1 reference

31 July 2017

volume

180

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

249-251

1 reference

Radial Scars in Benign Breast-Biopsy Specimens and the Risk of Breast Cancer

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

The Consensus Conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Indole-3-carbinol. A novel approach to breast cancer prevention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

Dose-ranging study of indole-3-carbinol for breast cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900453-0

10.1016/S0002-9610(00)00453-0

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference